Chairman’s remarks at AGM
At the shareholder’s annual meeting held today, the Chairman, John Kearney, made a presentation outlining the company’s plans for the coming year and his expectation that the price of zinc will move significantly higher in the near future, due to reduced production worldwide from mine closures and forecasts of increases in demand, and that these higher zinc prices would continue for a number of years.
Mr Kearney noted that the company had previously announced that it was updating its earlier scoping and economic studies on its Parys Mountain zinc/lead/copper/silver/gold property in Wales. He reported that this updated scoping study is being prepared by Micon International Limited and by Fairport Engineering Limited, both of which are acknowledged experts and leaders in the resources sector, and it is expected that the updated study will be presented to the company later in the autumn.
Grant of share options
The company also announces that it has today granted a total of 3,500,000 options to subscribe for ordinary shares at a price of 2 pence per share under the unapproved share option scheme to the directors in the amounts set out below:
Bill Hooley Chief Executive 1,000,000
Danesh Varma Finance Director 1,000,000
John Kearney Chairman 500,000
Howard Miller Non executive Director 500,000
David Lean Non executive Director 500,000
These share options, which were granted by the remuneration committee and approved by the board, will vest after one year from date of grant, with a term of five years expiring on the 30 September 2021. All options are subject to a performance criterion, namely that the company’s share price performance over the period from grant to exercise must exceed that of the companies in the top quartile of the FTSE 100 index.
The company points out that all the directors have waived entitlement to remuneration for more than the last 24 months.
Voting at the AGM
In respect of the voting at the company’s AGM held on 28 September 2016 the directors are pleased to report that all resolutions were passed unanimously on a show of hands.
The valid proxies recorded in respect of voting at the meeting were as follows:
|1||To receive the report and accounts||58,705,088||750||0|
|2||To approve the directors’ remuneration policy report||58,680,949||24,486||400|
|3||To approve the directors’ remuneration report||58,685,685||19,250||900|
|4||To reappoint John F. Kearney as a director||58,689,460||16,375||0|
|5||To reappoint Bill Hooley as a director||58,690,085||15,750||0|
|6||To reappoint David Lean as a director||58,690,585||15,750||500|
|7||To reappoint Howard Miller as a director||58,690,085||15,750||0|
|9||To reappoint Danesh Varma as a director||58,705,085||750||0|
|10||To reappoint Mazars LLP as auditors||58,703,035||750||2,050|
|11||To authorise the directors to determine the remuneration of the auditor||58,705,085||750||0|
|12||To authorise the directors to issue new share capital||58,683,724||21,611||500|
|13||To dis-apply pre-emption rights in respect of certain issues of shares||58,682,299||17,800||5,736|
1. Votes were received in respect of 58,705,835 shares representing 36.6% of the issued share capital.
2. Any proxy appointments which gave discretion to the chairman have been included in the “For” total.
3. The full text of the resolutions is shown in the notice of the AGM which is available in the annual report and on the website.
Total voting rights
The issued ordinary share capital of the company is 160,608,051 shares with voting rights; there are no shares in treasury.
The above figure may be used by shareholders as the denominator for the calculations which will determine whether they are required to notify their interest in the company, or any change to that interest, under the FSA’s Disclosure and Transparency Rules.
Following the grant of the share options set out above, the aggregate share options outstanding will represent 5.3% of the 160,608,051 ordinary shares in issue.
For further information, please contact:
Danesh Varma, Finance Director +44 (0)207 6539881;